The aromatic compound rifamycin SV binds to expanded and partially compact assembly intermediates and inhibits amyloid fibril formation of β2-microglobulin by diverting assembly toward soluble, toxic spherical aggregates lacking the classical structure of amyloid.
- Lucy A Woods
- Geoffrey W Platt
- Sheena E Radford